Condition
Lung Cancer – Malignant Pleural Mesothelioma
Estimated Enrollment: 27
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: UCL/12/0158|CMS # 1995|A15183|2012-001598-10|TBC
Study First Received: April 30, 2012
Last Updated: October 26, 2016
Estimated Primary Completion Date: September 2017
Primary Outcome Measures:
Maximum Tolerated Dose of Ganetespib|Progression Free Survival
Sponsors and Collaborators:
University College, London|Cancer Research UK
Website Link: https://ClinicalTrials.gov/show/NCT01590160
